Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
14.91
+0.79 (5.59%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $638.16 million as of October 9, 2026. It is the 13,183rd most valuable company in the world and the 2,586th biggest in the United States. Its market cap has increased by 170.67% in one year.
Market Cap
638.16M
Enterprise Value
468.01M
1-Year Change
170.67%
Global Rank
Country Rank
#2,586 United States
Category
ChartMarket Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has increased from $308.79M to $638.16M, an increase of 106.67%. That is a compound annual growth rate of 73.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 638.16M | 175.24% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zevra Therapeutics | 653.22M |
| Prime Medicine | 636.90M |
| Sagimet Biosciences | 632.51M |
| Climb Bio | 623.76M |
| Silence Therapeutics | 573.19M |
| CorMedix | 570.55M |
| Shattuck Labs | 568.06M |
| Electra Therapeutics | 566.79M |